AI drug discovery company
Transcripta Bio
Data as of .
Company facts
-
Founded
2020
-
Headquarters
United States (Palo Alto, CA)
-
Total funding
$34M
Latest funding round
- Round
- Funding since Series A
- Date
- Jul 21, 2026
- Amount
- $24M
- Lead investor
- Mayo Clinic and Omnimed (new investors)
Recent news
-
Research collaboration with Mayo Clinic on new ALS treatments
-
Transcripta Bio announces $24M in funding for its AI drug discovery platform in neurological and neuromuscular diseases
Confirmed means the company, a partner or a filing said it. Reported means a third party said it. This section sits outside the Pharma AI Tracker.
Spot an error? Tell me and I'll fix it.